| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2010/10/23 | 06:21 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:21 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:13 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:12 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/23 | 06:11 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/15 | 23:06 | Dow Jones News | Allos Granted Orphan Status In Europe For Lymphoma Drug | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/15 | 22:00 | Business Wire | Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Hodgkin Lymphoma by the Eu... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/11 | 21:19 | Dow Jones News | Allos' Pralatrexate Outperforms Tarceva In Lung-Cancer Study | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/11 | 20:15 | Business Wire | Allos Therapeutics Announces Presentation of Favorable Survival Data from Randomized Phase 2b Study of FOLOTYN® in Patients ... | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/10/04 | 23:00 | GlobeNewswire Inc. | Allos Therapeutics, Inc. (ALTH) to Ring The NASDAQ Stock Market Closing Bell | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/18 | 05:14 | Edgar (US Regulatory) | Amended Current report filing (8-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/18 | 05:13 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/16 | 06:40 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/16 | 06:38 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/16 | 06:37 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/16 | 06:35 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (3/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/13 | 22:00 | Business Wire | Allos Therapeutics to Present at Upcoming Investor Conferences | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/10 | 02:29 | Business Wire | Allos Therapeutics Announces FOLOTYN® Data Presentation at the 35th ESMO Congress | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/04 | 06:50 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/04 | 06:49 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/03 | 05:17 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/09/02 | 05:19 | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/08/25 | 19:06 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/07/31 | 05:17 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/07/28 | 20:53 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/07/28 | 20:50 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 2010/07/28 | 20:30 | Business Wire | Allos Therapeutics Reports Second Quarter 2010 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |